Chemoinformaics analysis of 2-Oxo-kolavenic acid
Molecular Weight | 318.457 | nRot | 4 |
Heavy Atom Molecular Weight | 288.217 | nRig | 14 |
Exact Molecular Weight | 318.219 | nRing | 2 |
Solubility: LogS | -3.67 | nHRing | 0 |
Solubility: LogP | 3.404 | No. of Aliphatic Rings | 2 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 55.8098 |
nHD | 1 | BPOL | 31.8322 |
QED | 0.759 |
Synth | 4.219 |
Natural Product Likeliness | 3.009 |
NR-PPAR-gamma | 0.159 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.677 |
Pgp-sub | 0.002 |
HIA | 0.005 |
CACO-2 | -5.15 |
MDCK | 0.0000228 |
BBB | 0.204 |
PPB | 0.920816 |
VDSS | 0.495 |
FU | 0.0737964 |
CYP1A2-inh | 0.019 |
CYP1A2-sub | 0.771 |
CYP2c19-inh | 0.102 |
CYP2c19-sub | 0.824 |
CYP2c9-inh | 0.347 |
CYP2c9-sub | 0.721 |
CYP2d6-inh | 0.056 |
CYP2d6-sub | 0.257 |
CYP3a4-inh | 0.031 |
CYP3a4-sub | 0.298 |
CL | 0.818 |
T12 | 0.877 |
hERG | 0.018 |
Ames | 0.006 |
ROA | 0.051 |
SkinSen | 0.964 |
Carcinogencity | 0.12 |
EI | 0.93 |
Respiratory | 0.949 |
NR-Aromatase | 0.597 |
Antiviral | Yes |
Prediction | 0.587555 |